Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/09/2023 | Xeris Biopharma Holdings, Inc. | | Purchase | Common Stock | 10k | $2.38 | $23.8k | | 08/09/2023 |
12/13/2022 | Xeris Biopharma Holdings, Inc. | | Purchase | Common Stock | 20k | $1.45 | $29k | | 12/13/2022 |
05/12/2022 | Xeris Biopharma Holdings, Inc. | | Purchase | Common Stock | 100k | $1.40 | $140.4k | | 05/12/2022 |
01/03/2022 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 600k | $0.00 | $0 | | 01/03/2022 |
11/15/2021 | Xeris Biopharma Holdings, Inc. | | Purchase | Common Stock | 20k | $2.28 | $45.7k | By: Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018 | 11/15/2021 |
11/11/2021 | Xeris Biopharma Holdings, Inc. | | Purchase | Common Stock | 200k | $2.08 | $415.8k | | 11/11/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Common Stock | 197.2k | $0.00 | $0 | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | | 410.8k | $0.00 | $0 | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Common Stock | 13.4k | $0.00 | $0 | By Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018 | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 668.1k | $1.55 | $1M | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 69.8k | $1.55 | $108.2k | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 98.3k | $5.93 | $582.6k | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 200k | $13.88 | $2.8M | | 10/05/2021 |
10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 400k | $5.08 | $2M | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 400k | $5.08 | $2M | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 200k | $13.88 | $2.8M | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 98.3k | $5.93 | $582.6k | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 69.8k | $1.55 | $108.2k | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 668.1k | $1.55 | $1M | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 13.4k | $0.00 | $0 | By Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018 | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | | 410.8k | $0.00 | $0 | | 10/05/2021 |
10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 197.2k | $0.00 | $0 | | 10/05/2021 |
01/29/2021 | XERIS PHARMACEUTICALS INC | XERS | Grant | Stock Option (Right to Buy) | 400k | $5.08 | $2M | | 01/29/2021 |
01/29/2021 | XERIS PHARMACEUTICALS INC | XERS | Grant | Common Stock | 225k | $0.00 | $0 | | 01/29/2021 |
12/09/2020 | XERIS PHARMACEUTICALS INC | XERS | Purchase | Common Stock | 10k | $4.06 | $40.6k | | 12/09/2020 |
06/05/2020 | Milestone Pharmaceuticals Inc. | MIST | Grant | Stock Option (right to buy) | 15k | $3.74 | $56.1k | | 06/05/2020 |
05/08/2020 | XERIS PHARMACEUTICALS INC | XERS | Purchase | Common Stock | 33k | $3.00 | $99k | | 05/08/2020 |
02/14/2020 | XERIS PHARMACEUTICALS INC | XERS | Purchase | Common Stock | 20k | $4.15 | $83k | | 02/14/2020 |
01/31/2020 | XERIS PHARMACEUTICALS INC | XERS | Grant | Common Stock | 185k | $0.00 | $0 | | 01/31/2020 |
01/31/2020 | XERIS PHARMACEUTICALS INC | XERS | Payment of Exercise | Common Stock | 9.8k | $6.37 | $62.4k | | 01/31/2020 |
11/25/2019 | XERIS PHARMACEUTICALS INC | XERS | Purchase | Common Stock | 17.9k | $8.55 | $153.3k | | 11/25/2019 |
05/24/2019 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Stock Units | 6.2k | $0.00 | $0 | | 05/24/2019 |
03/11/2019 | XERIS PHARMACEUTICALS INC | XERS | Purchase | Common Stock | 30k | $9.12 | $273.6k | | 03/11/2019 |
01/31/2019 | XERIS PHARMACEUTICALS INC | XERS | Grant | Common Stock | 125k | $0.00 | $0 | | 01/31/2019 |
01/31/2019 | XERIS PHARMACEUTICALS INC | XERS | Grant | Stock Option (right to buy) | 200k | $13.88 | $2.8M | | 01/31/2019 |
|